U-PLRX

Q:PLRX - PLIANT THERAPEUTICS INC - https://ir.pliantrx.com/

16:41:28 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PLRX - Q	0.1	34.68	·	36.54	2.0	34.87	-1.39	-3.8	1,038.8	36,450	8,284	36.17 36.64 34.87	36.50 3.965	16:10:08	16:03	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 8284

Time ET	Ex	Price	Change	Volume
16:10:08	Q	34.8815	-1.3785	30
16:05:24	Q	34.88	-1.38	1
16:04:22	Q	34.8685	-1.3915	8,922
16:04:07	Q	34.8675	-1.3925	1,565
16:00:36	Q	34.87	-1.39	20
16:00:26	Q	34.87	-1.39	700
16:00:25	Q	34.87	-1.39	3,244
16:00:04	Q	34.87	-1.39	277
16:00:04	Q	34.87	-1.39	45
16:00:04	Q	34.87	-1.39	1

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-01-27 16:03	U:PLRX	News Release200	Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters ¢ € ™ Option to Purchase Additional Shares
2023-01-25 08:01	U:PLRX	News Release200	Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer
2023-01-24 21:19	U:PLRX	News Release200	Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public Offering
2023-01-23 16:01	U:PLRX	News Release200	Pliant Therapeutics Announces Proposed Public Offering of Common Stock
2023-01-22 14:00	U:PLRX	News Release200	Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis
2023-01-03 08:00	U:PLRX	News Release200	Pliant Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Date ET

Symbol

Type

Headline

2023-01-27 16:03

U:PLRX

News Release

Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters ¢ € ™ Option to Purchase Additional Shares

2023-01-25 08:01

U:PLRX

News Release

Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer